Support Line: 0800 002 9002
General Enquiries: 01223 870008

Author Archive

Malcolm Packer

Malcolm is Chief Executive Officer at Kidney Cancer UK and Kidney Cancer Scotland and has worked with the charity in various capacities for over 15 years.
Adding Cabometyx to Immunotherapy Improves Kidney Cancer Outcomes

Adding Cabometyx to Immunotherapy Improves Kidney Cancer Outcomes

The addition of Cabometyx to Opdivo and Yervoy improved outcomes for patients with advanced kidney cancer, ...
Our Kidney Cancer Patient Survey 2022 Report

Our Kidney Cancer Patient Survey 2022 Report

Kidney cancer guidelines for doctors needed now In the week of Kidney Cancer Awareness Week 2023, Kidney ...
The importance of, and how to access, clinical trials #LWKCWebinar

The importance of, and how to access, clinical trials #LWKCWebinar

As part of Kidney Cancer Awareness Week 2023 we are delighted to be able to facilitate this free webinar with ...
Cancer & Mental Health: Let’s talk

Cancer & Mental Health: Let’s talk

By Lucy Willingale I was privileged to be asked by Cancer 52 to speak at a workshop at the NHS cancer ...
Kidney Cancer UK secure landmark kidney cancer NICE clinical guideline

Kidney Cancer UK secure landmark kidney cancer NICE clinical guideline

Kidney Cancer UK, the UK’s leading kidney cancer charity has, through its approach to NHS England, secured a ...
NHS gives GP teams direct access to tests to speed up cancer diagnosis

NHS gives GP teams direct access to tests to speed up cancer diagnosis

NHS Press Release (16th November 2022) Tens of thousands of cancers could be detected sooner each year thanks to ...
Pembrolizumab recommended as an adjuvant therapy for RCC across UK

Pembrolizumab recommended as an adjuvant therapy for RCC across UK

The Scottish Medical Consortium have recommended Pembrolizumab (Keytruda) as a monotherapy which is indicated for ...
No results found.